127
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Bicarbonate Therapy in Renally Compromised Critically Ill Patients with Metabolic Acidosis: Study of Clinical Outcomes and Mortality Rate

, ORCID Icon, , ORCID Icon, , & show all
Pages 2817-2826 | Published online: 24 Jun 2021

References

  • Ellis MF. Use of bicarbonate in patients with metabolic acidosis. Crit Care Nurse. 2015;35:73–75. doi:10.4037/ccn2015502
  • Kraut JA, Madias NE. Lactic acidosis. N Engl J Med. 2014;371:2309–2319. doi:10.1056/NEJMra1309483
  • Kraut JA, Madias NE. Lactic acidosis: current treatments and future directions. Am J Kidney Dis. 2016;68(3):473–482. doi:10.1053/j.ajkd.2016.04.020
  • Jung B, Rimmele T, Le Goff C, et al. Severe metabolic or mixed acidemia on intensive care unit admission: incidence, prognosis and administration of buffer therapy. A prospective, multiple-center study. Crit Care. 2011;15(5):238. doi:10.1186/cc10487
  • Moranne O, Froissart M, Rossert J, et al.; NephroTest Study Group. Timing of onset of CKD-related metabolic complications. J Am Soc Nephrol. 2009;20(1):164–171. doi:10.1681/ASN.2008020159
  • Lo KB, Garvia V, Stempel JM, Ram P, Rangaswami J. Bicarbonate use and mortality outcome among critically ill patients with metabolic acidosis: a meta analysis. Heart Lung. 2020;49(2):167–174.
  • Cooper DJ, Walley KR, Wiggs BR, Russell JA. Bicarbonate does not improve hemodynamics in critically III patients who have lactic acidosis: a prospective, controlled clinical study. Ann Intern Med. 1990;112(7):492–498. doi:10.7326/0003-4819-112-7-492
  • Sabatini S, Kurtzman NA. Bicarbonate therapy in severe metabolic acidosis. J Am Soc Nephrol. 2009;20(4):692–695. doi:10.1681/ASN.2007121329
  • Kraut JA, Madias NE. Metabolic acidosis: pathophysiology, diagnosis and management. Nat Rev Nephrol. 2010;6(5):274. doi:10.1038/nrneph.2010.33
  • Adeva-Andany MM, Fern andez-Fern Andez C, Mourino-Bayolo D, Castro-Quintela E, Domínguez-Montero A. Sodium bicarbonate therapy in patients with metabolic acidosis. Sci World J. 2014;2014:1–10. doi:10.1155/2014/627673
  • Fujii T, Udy A, Licari E, Romero L, Bellomo R. Sodium bicarbonate therapy for critically ill patients with metabolic acidosis: a scoping and a systematic review. J Crit Care. 2019;51:184–191. doi:10.1016/j.jcrc.2019.02.027
  • Jaber S, Paugam C, Futier E, et al. Sodium bicarbonate therapy for patients with severe metabolic acidaemia in the intensive care unit (BICAR-ICU): a multicentre, open-label, randomised controlled, Phase 3 trial. Lancet. 2018;392(10141):31–40. doi:10.1016/S0140-6736(18)31080-8
  • Kraut JA, Madias NE. Treatment of acute metabolic acidosis: a pathophysiologic approach. Nat Rev Nephrol. 2012;8:589–601. doi:10.1038/nrneph.2012.186
  • Brochard L, Abroug F, Brenner M, et al. An official ATS/ERS/ ESICM/SCCM/SRLF statement: prevention and management of acute renal failure in the ICU patient: an international consensus conference in intensive care medicine. Am J Respir Crit Care Med. 2010;181:1128–1155. doi:10.1164/rccm.200711-1664ST
  • Kraut JA, Madias NE. Consequences and therapy of the metabolic acidosis of chronic kidney disease. Pediatr Nephrol. 2011;26(1):19–28. doi:10.1007/s00467-010-1564-4
  • National Institute for Health and Care Excellence (NICE). Chronic kidney diseasse and acute kidney injury: assessment and management [Internet]. [London] NICE. (Clinical guideline [CG182]); January 2014 [updated April, 2015; cited September 8, 2020]. Available form: https://www.nice.org.uk/guidance/cg182/chapter/1-Recommendations#pharmacotherapy. Accessed June 7, 2021.
  • Kidney Disease. Improving Global Outcomes (KDIGO). Clinical practice guidelines for the evaluation and management of chronic kidney disease. chapter 2 definition, identification, and prediction of CKD progression & chapter 3 management of progression and complications of CKD [Internet]. KDIGO. 2012 [cited September 8, 2020]. Available form: https://kdigo.org/wp-content/uploads/2017/02/KDIGO_2012_CKD_GL.pdf. Accessed June 7, 2021.
  • Ali M, Naureen H, Tariq MH, et al. Rational use of antibiotics in an intensive care unit: a retrospective study of the impact on clinical outcomes and mortality rate. Infect Drug Resist. 2019;12:493–499. doi:10.2147/IDR.S187836
  • Raphael KL. Metabolic acidosis and subclinical metabolic acidosis in CKD. J Am Soc Nephrol. 2018;29(2):376–382. doi:10.1681/ASN.2017040422
  • Lemann JR, Litzow JR, Lennon EJ. The effects of chronic acid loads in normal man: further evidence for the participation of bone mineral in the defense against chronic metabolic acidosis. J Clin Invest. 1966;45(10):1608–1614. doi:10.1172/JCI105467
  • Bolvardi E, Malmir J, Reihani H, et al. The role of lactate clearance as a predictor of organ dysfunction and mortality in patients with severe sepsis. Mater Sociomed. 2016;28(1):57–60. doi:10.5455/msm.2016.28.57-60
  • Abramowitz MK. Metabolic acidosis and cardiovascular disease risk in CKD. Clin J Am Soc Nephrol. 2018;13(10):1451–1452. doi:10.2215/CJN.10120818
  • Tuomilehto J, Jousilahti P, Rastenyte D, Moltchanov V, Tanskanen A, Pietinen P. Urinary sodium excretion and cardiovascular mortality in Finland: a prospective study. Lancet. 2001;357(9259):848–851. doi:10.1016/S0140-6736(00)04199-4
  • Urso C, Brucculeri S, Caimi G. Acid-base and electrolyte abnormalities in heart failure: pathophysiology and implications. Heart Fail Rev. 2015;20(4):493–503. doi:10.1007/s10741-015-9482-y
  • Zheng CM, Liu WC, Zheng JQ, et al. Metabolic acidosis and strong ion gap in critically ill patients with acute kidney injury. Biomed Res Int. 2014;2014. doi:10.1155/2014/819528
  • Kitterer D, Schwab M, Alscher MD, Braun N, Latus J. Drug-induced acid-base disorders. Pediatr Nephrol. 2015;30(9):1407–1423. doi:10.1007/s00467-014-2958-5